1,220 research outputs found

    Zeewierteelt voor energie en industrie

    Get PDF
    Bedrijven gaan in de nabije toekomst mogelijk zeewieren kweken in onze Noordzee, op plantages voor de Nederlandse kust. De geteelde inheemse soorten leveren dan duurzame brandstoffen en grondstoffen voor de chemische industrie. Vanuit die visie werkt Ana López Contreras aan het project Zeewier Bioraffinage

    Batch fecundity of Sardina pilchardus off the Iberian Peninsula

    Get PDF
    Batch fecundity, the number of eggs released per spawning event, was determined for the first time in pilchard Sardina pilchardus (Walb.) off the Atlantic coast of the Iberian Peninsula. The mean relative fecundity (number of hydrated oocytes per gram of female weight was 416 (standard deviation = 112.9). Different regression models with Portuguese and Spanish data of batch fecundity by weight are presented. A linear model weighted least squares regression is established. The weighted regression presents a homogeneous distribution of the variance, small mean square error of the regression and highest R-squared, according whit this expression: F = -1260.8 + 444.43 W Linear regression of batch fecundity by age for Portugal data is: F = 30811.11 + 3711.88

    Prevalence of Bartonella henselae in blood donors and risk of blood transmission in Chile

    Get PDF
    Indexación: Scopus; Scielo.Bartonella henselae es el agente causal de la enfermedad del arañazo del gato en personas inmunocompetentes y de la angiomatosis bacilar y peliosis hepatis en inmunocomprometidos. En Chile la prevalencia de anticuerpos contra B. henselae en niños y adolescentes sanos es de 13,3%, en personas con riesgo ocupacional 60,5% y en gatos 85,6%. No existen datos publicados respecto de la seroprevalencia en donantes de sangre en nuestro país, por lo que determinar si B. henselae se encuentra presente en la sangre de los donantes al momento de la donación es muy importante, ya que este microorganismo puede sobrevivir hasta 35 días en los eritrocitos almacenados en banco de sangre a 4 °C. Objetivo: Determinar la prevalencia de B. henselae en donantes de sangre. Metodología: Se analizaron 140 muestras de sangre de donantes, para detectar la presencia de B. henselae, utilizando la técnica de la reacción de polimerasa en cadena (RPC). Resultados: Se obtuvo 13,6% de los donantes de sangre con RPC positiva para la B. henselae. La secuencia de los fragmentos amplificados presentó una identidad por sobre 98% con respecto a secuencias de B. henselae de referencia. Conclusión: El riesgo de transmisión sanguínea debiera ser considerado en un país con alta seroprevalencia de infección por B. henselae.Bartonella henselae is the causal agent of cat scratch disease in immunocompetent persons and bacterial angiomatosis in immunocompromised patients. In Chile, the prevalence of antibodies against B. henselae in healthy children and adolescents is 13.3%, in persons with occupational risk 60.5%, and in cats 85.6%. There are no published data regarding the seroprevalence in blood donors in our country, so determining if B. henselae is present in the blood of donors at the time of donation is very important, since this microorganism can survive up to 35 days in the red blood cells stored in a blood bank at 4 °C. Objective: To determine the prevalence of B. henselae in blood donors. Methodology: 140 donor blood samples were analyzed to detect the presence of B. henselae, using the polymerase chain reaction technique. Results: 13.6% of the blood donors with positive polymerase chain reaction for B. henselae were obtained. The sequence of the amplified fragments showed an identity of over 98% with respect to B. henselae reference sequences. Conclusion: The risk of blood transmission is due to a country with high B. henselae infection.https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182017000600539&lng=en&nrm=iso&tlng=e

    The length and depth of real algebraic groups

    Full text link
    Let GG be a connected real algebraic group. An unrefinable chain of GG is a chain of subgroups G=G0>G1>...>Gt=1G=G_0>G_1>...>G_t=1 where each GiG_i is a maximal connected real subgroup of Gi1G_{i-1}. The maximal (respectively, minimal) length of such an unrefinable chain is called the length (respectively, depth) of GG. We give a precise formula for the length of GG, which generalises results of Burness, Liebeck and Shalev on complex algebraic groups and also on compact Lie groups. If GG is simple then we bound the depth of GG above and below, and in many cases we compute the exact value. In particular, the depth of any simple GG is at most 99

    Thy-1 (CD90)-Induced Metastatic Cancer Cell Migration and Invasion Are β3 Integrin-Dependent and Involve a Ca<sup>2+</sup>/P2X7 Receptor Signaling Axis.

    Get PDF
    Cancer cell adhesion to the vascular endothelium is an important step in tumor metastasis. Thy-1 (CD90), a cell adhesion molecule expressed in activated endothelial cells, has been implicated in melanoma metastasis by binding to integrins present in cancer cells. However, the signaling pathway(s) triggered by this Thy-1-Integrin interaction in cancer cells remains to be defined. Our previously reported data indicate that Ca &lt;sup&gt;2+&lt;/sup&gt; -dependent hemichannel opening, as well as the P2X7 receptor, are key players in Thy-1-α &lt;sub&gt;V&lt;/sub&gt; β &lt;sub&gt;3&lt;/sub&gt; Integrin-induced migration of reactive astrocytes. Thus, we investigated whether this signaling pathway is activated in MDA-MB-231 breast cancer cells and in B16F10 melanoma cells when stimulated with Thy-1. In both cancer cell types, Thy-1 induced a rapid increase in intracellular Ca &lt;sup&gt;2+&lt;/sup&gt; , ATP release, as well as cell migration and invasion. Connexin and Pannexin inhibitors decreased cell migration, implicating a requirement for hemichannel opening in Thy-1-induced cell migration. In addition, cell migration and invasion were precluded when the P2X7 receptor was pharmacologically blocked. Moreover, the ability of breast cancer and melanoma cells to transmigrate through an activated endothelial monolayer was significantly decreased when the β &lt;sub&gt;3&lt;/sub&gt; Integrin was silenced in these cancer cells. Importantly, melanoma cells with silenced β &lt;sub&gt;3&lt;/sub&gt; Integrin were unable to metastasize to the lung in a preclinical mouse model. Thus, our results suggest that the Ca &lt;sup&gt;2+&lt;/sup&gt; /hemichannel/ATP/P2X7 receptor-signaling axis triggered by the Thy-1-α &lt;sub&gt;V&lt;/sub&gt; β &lt;sub&gt;3&lt;/sub&gt; Integrin interaction is important for cancer cell migration, invasion and transvasation. These findings open up the possibility of therapeutically targeting the Thy-1-Integrin signaling pathway to prevent metastasis

    Quantification of pharmacokinetic profiles of PD-1/PD-L1 antibodies by validated ELISAs

    Get PDF
    Immunotherapy has changed the paradigm of cancer treatments. In this way, several combinatorial strategies based on monoclonal antibodies (mAb) such as anti (a)-PD-1 or anti (a)-PD-L1 are often reported to yield promising clinical benefits. However, the pharmacokinetic (PK) behavior of these mAbs is a critical issue that requires selective analytical techniques. Indeed, few publications report data on a-PD1/a-PD-L1 exposure and its relationship with therapeutic or toxic effects. In this regard, preclinical assays allow the time profiles of antibody plasma concentrations to be characterized rapidly and easily, which may help to increase PK knowledge. In this study, we have developed and validated two in-house ELISAs to quantify a-PD-1 and a-PD-L1 in plasma collected from tumor-bearing mice. The linear range for the a-PD-1 assay was 2.5–125 ng/mL and 0.11–3.125 ng/mL for the a-PD-L1 assay, whereas the intra-and inter-day precision was lower than 20% for both analytes. The PK characterization revealed a significant decrease in drug exposure after administration of multiple doses. Plasma half-life for a-PD-1 was slightly shorter (22.3 h) than for a-PD-L1 (46.7 h). To our knowledge, this is the first reported preclinical ELISA for these immune checkpoint inhibitors, which is sufficiently robust to be used in different preclinical models. These methods can help to understand the PK behavior of these antibodies under different scenarios and the relationship with response, thus guiding the choice of optimal doses in clinical settings
    corecore